background preloader

The Potential Impact of Biofield Treatment on Human Brain Tumor Cells

The Potential Impact of Biofield Treatment on Human Brain Tumor Cells
Open Access o u r n a l f t e g i v c y Integrative Oncology Research Article Trivedi et al., J Integr Oncol 2015, 4:3 J Integr Oncol ISSN: 2329-6771 JIO, an open access journal Volume 4 • Issue 3 • 1000141 Keywords: Glial cell; Glioblastoma; Brain tumor; Bioeld treatment; Time-lapse video microscopy Introduction Brain tumors are typically very heterogeneous, aggressive neoplasms at the cellular level which aects both children and adults [1]. individuals born today with brain cancer at dierent point of life. U.S., 22,850 men and women are diagnosed with brain cancer every year, and 15,320 deaths are caused by this disease [2]. organization classication, glioblastoma (GBM) is also known as grade IV astrocytoma [3]. brain tumor. 12 months [4]. assess cellular behavior in real time. a two dimensional image data at dierent time intervals. data are converted to make a movie. in various elds of cancer and stem cell biology for assessment of now a days. Globe. Abstract

The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time-Lapse Video Microscopy Title: The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time-Lapse Video Microscopy Select license: Creative Commons Attributions-NonCommercial-ShareAlike Updated: November 19th, 2016 Abstract: Study background: Glioblastoma (GBM) is the most common subtype of primary brain tumor in adults. Methods: The human brain tumor, GBM cultured cells were divided into two groups viz. Results: GBM control cells showed a basal level of cell death 10 hours prior and 10 hours after the biofield treatment, and the rate remained unchanged over the 20 hours period, while in treatment group of GBM, cell death rate was exponentially increased (41%) after biofield treatment as compared to control.

"The Potential Impact of Biofield Treatment on Human Brain Tumor Cells:" by Mahendra Kumar Trivedi Description Study background: Glioblastoma (GBM) is the most common subtype of primary brain tumor in adults. The aim was to evaluate the impact of biofield treatment potential on human GBM and non-GBM brain cells using two time-lapse video microscopy technique. Methods: The human brain tumor, GBM cultured cells were divided into two groups viz. GBM control and GBM treatment. Similarly, human normal brain cultured cells (non-GBM) were taken and divided into two groups viz. non- GBM control and non-GBM treatment. Citation Information Mahendra Kumar Trivedi. The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time-Lapse Video Microscopy | Open Access | OMICS International Abstract Study background: Glioblastoma (GBM) is the most common subtype of primary brain tumor in adults. The aim was to evaluate the impact of biofield treatment potential on human GBM and non-GBM brain cells using two time-lapse video microscopy technique. Methods: The human brain tumor, GBM cultured cells were divided into two groups viz. Results: GBM control cells showed a basal level of cell death 10 hours prior and 10 hours after the biofield treatment, and the rate remained unchanged over the 20 hours period, while in treatment group of GBM, cell death rate was exponentially increased (41%) after biofield treatment as compared to control. Conclusion: Altogether, data suggests that biofield treatment has significantly increased the cell death rate of treated GBM cells and simultaneously boost the viability of normal brain cells.

Bio-field Treatment: An Effective Strategy to Improve the Quality of Beef Extract and Meat Infusion Powder Share this: Embed* Cite this: Trivedi, Mahendra Kumar (2015): Bio-field Treatment: An Effective Strategy to Improve the Quality of Beef Extract and Meat Infusion Powder. figshare. Retrieved 10:40, Nov 19, 2015 (GMT) *The embed functionality can only be used for non commercial purposes. Description The present research work investigated the influence of bio-field treatment on two common flavoring agents usedin food industries namely beef extract powder (BEP) and meat infusion powder (MIP). Comments (0) Published on 03 Sep 2015 - 14:18 (GMT) Filesize is 2.12 MB License (what's this?) Cite "Filename" Place your mouse over the citation text to select it Embed "Bio-field Treatment: An Effective Strategy to Improve the Quality of Beef Extract and Meat Infusion Powder" Show filename on top Place your mouse over the embed code to select and copy it

Publication meta - The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time-Lapse Video Microscopy - Publications Study background: Glioblastoma (GBM) is the most common subtype of primary brain tumor in adults. The aim was to evaluate the impact of biofield treatment potential on human GBM and non-GBM brain cells using two time-lapse video microscopy technique. Methods: The human brain tumor, GBM cultured cells were divided into two groups viz. GBM control and GBM treatment. Similarly, human normal brain cultured cells (non-GBM) were taken and divided into two groups viz. non- GBM control and non-GBM treatment. The GBM and non-GBM treatment groups were given Mr. Loop | Evaluation of Biofield Modality on Viral Load of Hepatitis B and C Viruses Study background: Nowadays, hepatitis is a major challenge for clinical research, regulatory bodies, and clinicians who are trying to assess the more effectiveness of antiviral therapy against patients. Viral load count is the amount of particular viral DNA or RNA in a blood samples. It is one of the surrogate biomarker of hepatitis. High viral load indicates that the immune system is failed to fight against viruses. Method: The viral load assay was performed on stock human plasma samples of HBV and HCV before and after 7 days of biofield treatment using Roche COBAS® AMPLICOR analyzer according to manufacturer’s instructions. Result: The viral load of HBV DNA in infected plasma samples showed a significant alteration in the biofield treated group as compared to control. Keywords: Hepatitis B virus, Hepatitis C virus, Biofield Treatment, Viral Load, HBV DNA and HCV RNA.

The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time-Lapse Video Microscopy Share this: Embed* Cite this: Trivedi, Mahendra Kumar (2015): The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time-Lapse Video Microscopy. figshare. Retrieved 06:06, Dec 04, 2015 (GMT) *The embed functionality can only be used for non commercial purposes. Description Study background: Glioblastoma (GBM) is the most common subtype of primary brain tumor in adults. Methods: The human brain tumor, GBM cultured cells were divided into two groups viz. Results: GBM control cells showed a basal level of cell death 10 hours prior and 10 hours after the biofield treatment, and the rate remained unchanged over the 20 hours period, while in treatment group of GBM, cell death rate was exponentially increased (41%) after biofield treatment as compared to control. Comments (0) Published on 30 Oct 2015 - 14:09 (GMT) Filesize is 554.87 KB License (what's this?) Cite "Filename" Place your mouse over the citation text to select it

"An Effect of Biofield Treatment on Multidrug-resistant Burkholderia ce" by Mahendra Kumar Trivedi Abstract Burkholderia cepacia (B. cepacia) is an opportunistic, Gram negative pathogen which causes infection mainly in immunocompromised population and associated with high rate of morbidity and mortality in cystic fibrosis patients. Aim of the present study was to analyze the impact of biofield treatment on multidrug resistant B. cepacia. Citation Information Mahendra Kumar Trivedi.

Impact of Biofield Treatment on Enterobacter Aerogenes Abstract: Enterobacter aerogenes (E. aerogenes) has been reported as the versatile opportunistic pathogen associated with the hospital infections worldwide. The aim of the study was to determine the impact of Mr. Trivedi’s biofield energy treatment on multidrug resistant clinical lab isolates (LSs) of E. aerogenes. The MDR isolates of E. aerogenes (i.e., LS 45 and LS 54) were divided into two groups, i.e., control and treated. Samples were analyzed for antimicrobial susceptibility pattern, minimum inhibitory concentration (MIC), biochemical study, and biotype number using MicroScan Walk-Away® system, on day 10 after the biofield treatment. Keywords: Enterobacter aerogenes; Multidrug resistant; Antimicrobial susceptibility; Biofield treatment; Biochemical reactions; Biotyping Introduction Enterobacter is a genus of Gram-negative, rod shaped, facultative anaerobic, and non-spore forming microbes of family Enterobacteriaceae. Materials and Methods Inoculum preparation Biofield treatment Results

Publication meta - Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen - Publications Antimicrobial Susceptibility, Biochemical Characterization and Molecular Typing of Biofield Treated Klebsiella pneumoniae - Trivedi Science Abstract: Pathogenic isolates of Klebsiella pneumoniae (K. pneumoniae), particularly the extended-spectrum β-lactamase (ESBL) producing strains, are mostly associated with the failure of antibiotic therapy in nosocomial infections. The present work was designed to evaluate the impact of Mr. Trivedi’s biofield energy treatment on phenotypic and genotypic characteristics of K. pneumoniae. Keywords: Klebsiella pneumoniae; Biofield energy treatment; Antibiogram, Biochemical reactions, Polymorphism; Random Amplified Polymorphic DNA. Abbreviations: CAM: Complementary and Alternate Medicine; NHIS: National Health Interview Survey; NCHS: National Center for Health Statistics; ATCC: American Type Culture Collection; MIC: Minimum Inhibitory Concentration; MEGA: Molecular Evolutionary Genetics Analysis; NBPC 30: Negative Breakpoint Combo Panel 30; RAPD: Random Amplified Polymorphic DNA; PCR: Polymerase chain reaction; ESBL: Extended Spectrum β-Lactamase Introduction Materials and Methods Biotype number

"Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobac" by Mahendra Kumar Trivedi Description Citrobacter braakii (C. braakii) is widespread in nature, mainly found in human urinary tract. The current study was attempted to investigate the effect of Mr. Trivedi’s biofield treatment on C. braakii in lyophilized as well as revived state for antimicrobial susceptibility pattern, biochemical characteristics, and biotype number. Lyophilized vial of ATCC strain of C. braakii was divided into two parts, Group (Gr.) Citation Information Trivedi MK, Branton A, Trivedi D, Nayak G, Charan S, et al. (2015) Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen.

Impact of Biofield Treatment on Klebsiella Pneumoniae Abstract Increasing cancer rates particularly in the developed world are associated with related lifestyle and environmental exposures. Combined immunotherapy and targeted therapies are the main treatment approaches in advanced and recurrent cancer. Keywords: Biofield treatment; Cancer biomarker; ELISA; TNF-α; IL-6; Prostate cancer; Endometrium cancer Introduction Cancer has the potential to invade or spread to other parts of the body which involves abnormal cell growth. Role of immune cells estimation in microenvironment of tumor has been well established. In the last 70 years, cancer treatment strategies have rapidly increased. Materials and Methods Experimental design Endometrium and prostate cancer cell lines, as stock stored cultures were procured for the experiment from department of laboratory medicine, P.D. Biofield treatment modalities Endometrium and prostate cancer cell lines were taken for biofield treatment. Measurement of diagnostic cancer biomarkers Results and Discussion 1.

Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii Research Article Open Access Trivedi et al., J Clin Med Genom 2015, 3:1 Volume 3 • Issue 1 • 1000129 J Clin Med Genom ISSN: IJGM, an open access journal Journal of Clinical & Medical Genomics Keywords: Citrobacter braakii; Antimicrobial susceptibility; Bioeld treatment; Biochemical reaction; Biotype; 16S rDNA analysis; Gram- negative bacteria; Enterobacteriaceae Abbreviations: MDR: Multi-Drug Resistant; ATCC: American Type Culture Collection; NBPC 30: Negative Breakpoint Combo 30; MIC: Minimum Inhibitory Concentration; OTUs: Operational Taxonomic Units; NCBI: National Center for Biotechnology Information; MEGA: Molecular Evolutionary Genetics Analysis; PCR: Polymerase Chain Reaction; RDP: Ribosomal Database Project; HBMEC: Human Brain Microvascular Endothelial Cells Introduction Citrobacter braakii (C. braakii) is a genus of Gram-negative, straight, facultative anaerobic and motile bacilli bacterium widely distributed in water, soil, and food in the environment.

Related: